{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:50:12Z","timestamp":1757699412890},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s00347-004-1065-6","type":"journal-article","created":{"date-parts":[[2004,7,13]],"date-time":"2004-07-13T08:19:45Z","timestamp":1089706785000},"page":"58-63","source":"Crossref","is-referenced-by-count":5,"title":["Passagere Visusminderung nach photodynamischer Therapie"],"prefix":"10.1007","volume":"102","author":[{"given":"S.","family":"Mennel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Hausmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. H.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"H\ufffdrle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0161-6420(02)01998-X","volume":"110","author":"Blinder","year":"2003","unstructured":"Blinder KJ, Blumenkranz MS, Bressler NM et al. (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial ? VIP report no. 3. Ophthalmology 110:667?673","journal-title":"Ophthalmology"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00006982-200304000-00004","volume":"23","author":"Costa","year":"2003","unstructured":"Costa RA, Farah ME, Cardillo JA et al. (2003) Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina 23:159?165","journal-title":"Retina"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0161-6420(98)93601-6","volume":"105","author":"Hee","year":"1998","unstructured":"Hee MR, Puliafito CA, Duker JS (1998) Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 105:360?370","journal-title":"Ophthalmology"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archopht.1996.01100140186012","volume":"114","author":"Husain","year":"1996","unstructured":"Husain D, Miller JW, Michaud N et al. (1996) Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol 114:978?985","journal-title":"Arch Ophthalmol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0161-6420(96)30675-1","volume":"103","author":"Kramer","year":"1996","unstructured":"Kramer M, Miller JW, Michaud N et al. (1996) Liposomal benzoporphyrin derivate verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Ophthalmology 103:427?438","journal-title":"Ophthalmology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/archopht.119.8.1135","volume":"119","author":"Massin","year":"2001","unstructured":"Massin P, Vicaut E, Haouchine B et al. (2001) Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 119:1135?1142","journal-title":"Arch Ophthalmol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0002-9394(03)00338-6","volume":"136","author":"Mennel","year":"2003","unstructured":"Mennel S, Schmidt JC, Meyer CH (2003) Therapeutic strategies in choroidal neovascularizations secondary to angioid streaks. Am J Ophthalmol 136:580?582","journal-title":"Am J Ophthalmol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF03163276","volume":"18","author":"Mennel","year":"2004","unstructured":"Mennel S, Meyer CH, Schmidt JC, Rodrigues EB (2004) Dreidimensionale optische Koh\u00e4renztomographie zur Verlaufskontrolle von Makula\u00f6demen nach intravitrealer Triamcinolonapplikation. Spektrum Augenheilkd 18:48?54","journal-title":"Spektrum Augenheilkd"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1167\/iovs.02-0604","volume":"44","author":"Michels","year":"2003","unstructured":"Michels S, Schmidt-Erfurth U (2003) Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci 44:2147?2154","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00347-002-0723-9","volume":"100","author":"Muller-Velten","year":"2003","unstructured":"Muller-Velten R, Michels S, Schmidt-Erfurth U, Laqua H (2003) Photodynamic therapy: extended indication. Ophthalmologe 100:384?390","journal-title":"Ophthalmologe"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0161-6420(02)01968-1","volume":"110","author":"Porrini","year":"2003","unstructured":"Porrini G, Giovannini A, Amato G et al. (2003) Photodynamic therapy of circumscribed choroidal hemangioma. Ophthalmology 110:674?680","journal-title":"Ophthalmology"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0002-9394(02)01566-0","volume":"134","author":"Rogers","year":"2002","unstructured":"Rogers AH, Martidis A, Greenberg PB, Puliafito CA (2002) Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 134:566?576","journal-title":"Am J Ophthalmol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0161-6420(13)31079-3","volume":"101","author":"Schmidt-Erfurth","year":"1994","unstructured":"Schmidt-Erfurth U, Hasan T, Gragoudas E et al. (1994) Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 101:1953?1961","journal-title":"Ophthalmology"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s003470170189","volume":"98","author":"Schmidt-Erfurth","year":"2001","unstructured":"Schmidt-Erfurth U, Laqua H (2001) Photodynamic therapy: Recommendations for indication and treatment. Ophthalmologe 98:216?219","journal-title":"Ophthalmologe"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/bjo.85.9.1086","volume":"85","author":"Schnurrbusch","year":"2001","unstructured":"Schnurrbusch UEK, Welt K, Horn LC, Wiedemann P, Wolf S (2001) Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. Br J Ophthalmol 85:1086?1091","journal-title":"Br J Ophthalmol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Treatment","year":"1999","unstructured":"Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year result of 2 randomized clinical trial?TAP report. Arch Ophthalmol 117:1329?1345","journal-title":"Arch Ophthalmol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9394(01)00967-9","volume":"131","author":"Verteporfin","year":"2001","unstructured":"Verteporfin in Photodynamic Therapy Study Group (2001) Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year result of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization?verteporfin in photodynamic therapy report 2. Am J Ophthalmol 131:541?560","journal-title":"Am J Ophthalmol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00006982-200202000-00003","volume":"22","author":"Verteporfin","year":"2002","unstructured":"Verteporfin Roundtable 2000 and 2001 Participants; Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group principal investigators; Verteporfin in photodynamic therapy (VIP) study group principal investigators (2002) Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 22:6?18","journal-title":"Retina"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-004-1065-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-004-1065-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-004-1065-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:46:32Z","timestamp":1559036792000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-004-1065-6"}},"subtitle":["Ein refraktives Problem?"],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1007\/s00347-004-1065-6","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}